At 14.12 UTC, the difference between the spotted C difficile and the double anaerobic strain was about one third the size that is expected for an aiboresis.
The one immunosuppressant antibody found with C difficile, called USCID-19, had a different immune reaction depending on the strain, suggesting that this immunosuppressant antibody may be altered by the type of C difficile that it is being fought.
Columbia University is leading the US investigation with Loyola University in Chicago and Texas A&M University in Corpus Christi. The team is hopeful that their findings will shed new light on the cause of this particular C difficile problem and point to some possible targets for new drugs.
This letter and database page contain a summary of what we know about this outbreak.
Updated in January 21: Chemical reactions are already being used to investigate different molecules that may play a role in causing or controlling the spore’s growth.
Note: This article does not purport to present a scientific opinion.